- €847.42m
- €953.43m
- €1.24bn
- 94
- 72
- 49
- 85
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,214 | 1,067 | 1,178 | 1,337 | 1,240 |
Cost of Revenue | |||||
Gross Profit | 501 | 424 | 473 | 526 | 493 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,105 | 1,015 | 1,104 | 1,256 | 1,201 |
Operating Profit | 109 | 52.4 | 73.9 | 80.8 | 38.9 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 101 | 46.6 | 72.8 | 75.9 | 30.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | 74.7 | 37.2 | 57 | 59.3 | 24.6 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 74.7 | 37.2 | 57 | 59.3 | 24.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 74.7 | 37.2 | 57 | 59.3 | 24.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.14 | 0.618 | 0.901 | 1.09 | 0.841 |
Dividends per Share |